Boomerang Medical is a startup based in the United States, most recent round Series B, 2 tracked investors.
Based in the United States, Boomerang Medical is a startup founded in 2018. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Boomerang Medical develops bioelectric neuromodulation technology for treating autoimmune diseases, specifically focusing on inflammatory bowel disease such as Crohn's disease and ulcerative colitis, and is conducting FDA-approved clinical trials.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.